Position in ANAB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,202,309
+$412,106 QoQ
Shares Held
417,812
-44.4% QoQ
Ownership
1.44%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. ANAB ranks #71 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,202,309 | 417,812 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $27,790,203 | 501,086 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $6,339,583 | 130,767 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,896,111 | 127,241 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $23,904,937 | 1,076,799 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $21,266,139 | 1,143,959 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $237,645 | 17,949 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $5,568,896 | 166,236 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,606,270 | 104,001 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,227,899 | 54,525 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $544,388 | 25,415 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,091,945 | 60,799 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,447,204 | 120,315 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,497,204 | 114,761 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,428,933 | 78,378 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,067,562 | 81,049 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $943,580 | 46,482 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $846,402 | 34,212 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $335,615 | 9,658 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $386,133 | 14,238 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $403,183 | 15,549 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $1,112,584 | 51,628 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $227,683 | 10,590 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $245,113 | 16,618 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $520,095 | 23,281 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,803,637 | 127,646 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||